Linvoseltamab
R5458-ONC-2257
Phase 2 small_molecule active
Quick answer
Linvoseltamab for Monoclonal Gammopathy of Undetermined Significance (MGUS) is a Phase 2 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active